|
Apr 24
|
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
|
|
Apr 21
|
Champions Oncology Inc (CSBR) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Apr 13
|
Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year
|
|
Mar 13
|
Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024)
|
|
Mar 11
|
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
|
|
Feb 18
|
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
|
|
Oct 9
|
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Oct 9
|
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
|
|
Apr 17
|
Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely?
|
|
Mar 19
|
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript
|
|
Mar 12
|
Champions Oncology Reports Quarterly Revenue of $12.0 Million
|
|
Mar 7
|
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
|
|
Mar 6
|
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
|
|
Mar 5
|
Pleasing Signs As A Number Of Insiders Buy Champions Oncology Stock
|
|
Dec 4
|
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
|